Literature DB >> 9013703

BMP7 null mutation in mice: developmental defects in skeleton, kidney, and eye.

N Jena1, C Martín-Seisdedos, P McCue, C M Croce.   

Abstract

While generating bcl2 alpha transgenic mice, we found some F2 offspring of one of the transgenic lines which were very small and had closed eyes at the time of weaning. These pups died within 1 month after birth. In order to determine the molecular basis of this phenotype, we screened a genomic library of the above transgenic line with a transgene-specific probe and found that the Bmp7 gene, a member of the TGF beta superfamily, was inactivated by insertional mutagenesis due to transgene integration. The Bmp7 homozygous null condition in mice is a postnatal lethal mutation and is associated with various developmental defects: holes in the basisphenoid bone and the xyphoid cartilage, retarded ossification of bones, fused ribs and vertebrae, underdeveloped neural arches of the lumbar and sacral vertebrae, polydactyly of the hind limbs, a kinked tail, a reduced number of nephrons, polycystic kidney, lack of retinal pigmentation, and retarded lens development. These findings indicate that BMP7 is an important signaling molecule for normal development of the mammalian skeleton, kidney, and eye. Academic Press

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9013703     DOI: 10.1006/excr.1996.3411

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  57 in total

1.  Patterning of the hepato-pancreatobiliary boundary by BMP reveals heterogeneity within the murine liver bud.

Authors:  Amrita Palaria; Jesse R Angelo; Taylor M Guertin; Jesse Mager; Kimberly D Tremblay
Journal:  Hepatology       Date:  2018-05-09       Impact factor: 17.425

Review 2.  Molecular mechanisms of optic vesicle development: complexities, ambiguities and controversies.

Authors:  Ruben Adler; M Valeria Canto-Soler
Journal:  Dev Biol       Date:  2007-02-07       Impact factor: 3.582

Review 3.  Prenatal programming-effects on blood pressure and renal function.

Authors:  Eberhard Ritz; Kerstin Amann; Nadezda Koleganova; Kerstin Benz
Journal:  Nat Rev Nephrol       Date:  2011-02-01       Impact factor: 28.314

4.  BMP7 inhibits branching morphogenesis in the prostate gland and interferes with Notch signaling.

Authors:  Irina B Grishina; Sung Yup Kim; Christopher Ferrara; Helen P Makarenkova; Paul D Walden
Journal:  Dev Biol       Date:  2005-12-15       Impact factor: 3.582

5.  BMP7: a new bone metastases prevention?

Authors:  Pierrick G J Fournier; Theresa A Guise
Journal:  Am J Pathol       Date:  2007-08-09       Impact factor: 4.307

Review 6.  Molecular basis for skeletal variation: insights from developmental genetic studies in mice.

Authors:  C Kappen; A Neubüser; R Balling; R Finnell
Journal:  Birth Defects Res B Dev Reprod Toxicol       Date:  2007-12

7.  Noggin producing, MyoD-positive cells are crucial for eye development.

Authors:  Jacquelyn Gerhart; Jessica Pfautz; Christine Neely; Justin Elder; Kevin DuPrey; A Sue Menko; Karen Knudsen; Mindy George-Weinstein
Journal:  Dev Biol       Date:  2009-09-22       Impact factor: 3.582

8.  Functions of the type 1 BMP receptor Acvr1 (Alk2) in lens development: cell proliferation, terminal differentiation, and survival.

Authors:  Ramya Rajagopal; Lisa K Dattilo; Vesa Kaartinen; Chu-Xia Deng; Lieve Umans; An Zwijsen; Anita B Roberts; Erwin P Bottinger; David C Beebe
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-06-19       Impact factor: 4.799

9.  Conditional deletion of BMP7 from the limb skeleton does not affect bone formation or fracture repair.

Authors:  Kunikazu Tsuji; Karen Cox; Laura Gamer; Daniel Graf; Aris Economides; Vicki Rosen
Journal:  J Orthop Res       Date:  2010-03       Impact factor: 3.494

10.  BMP-7 and proximal tubule epithelial cells: activation of multiple signaling pathways reveals a novel anti-fibrotic mechanism.

Authors:  Reza Motazed; Paul Colville-Nash; Jonathan T C Kwan; Mark E C Dockrell
Journal:  Pharm Res       Date:  2008-02-21       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.